Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...

Around half of study participants, all age 65 or younger, wouldn’t have been eligible for statins if they’d sought care 2 ...

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one ...

Once-weekly semaglutide 2.4 mg reduced the risk for major adverse cardiovascular events among adults with overweight or obesity who were at risk for atherosclerotic cardiovascular disease, according ...

NEW ORLEANS, LOUISIANA / ACCESS Newswire / November 12, 2025 / American Heart Association (“AHA”) Conference 2025, GENinCode ...

Factors linked to heart problems, such as high blood pressure, diabetes and bad cholesterol levels, can start years, ...

Discover Enlicitide, a new daily pill for genetic high cholesterol (HeFH). A recent trial shows it lowers bad LDL cholesterol ...

Accenture has invested, through Accenture Ventures, in Alembic, a leading AI-powered causal marketing intelligence platform that can determine which marketing campaigns deliver a return on investment ...

Applied DNA Sciences, Inc. (the "Company") today announced that it will change its name to BNB Plus Corp. ("BNB Plus"), reflecting the Company's commitment to delivering a yield-optimized, BNB-based ...

Objectives Heart failure (HF), chronic kidney disease (CKD) and atherosclerotic cardiovascular disease (ASCVD) are highly prevalent conditions that often coexist. Using electronic health records (EHRs ...

NewAmsterdam Pharma gains from strong phase 3 obicetrapib results, LDL-C reduction and expansion into diabetes and ...